Rheumatoid Arthritis and Blood Pressure Management

The European Society of Cardiology recommends that rheumatoid arthritis-associated inflammation directly affects cardiovascular parameters, including blood pressure, contributing to endothelial dysfunction and vascular changes that promote hypertension independent of traditional risk factors 1, 2, 3
The inflammatory burden itself drives blood pressure elevation, though intensive RA treatment may mitigate or even reverse this effect, according to the Annals of the Rheumatic Diseases 2

Medication-Induced Blood Pressure Changes

The American College of Cardiology suggests that when antihypertensive therapy is indicated, ACE inhibitors and angiotensin II blockers are preferred first-line agents due to potential anti-inflammatory properties, which may favorably affect inflammatory markers and endothelial function in RA beyond their BP-lowering effects 4, 5, 6

The American Heart Association recommends a target systolic blood pressure of 120-129 mmHg if well tolerated, with treatment threshold at ≥140/90 mmHg, and combination therapy with ACE inhibitor or ARB plus either dihydropyridine calcium channel blocker or thiazide/thiazide-like diuretic should be initiated for confirmed hypertension 7
The Annals of the Rheumatic Diseases suggests that assessing cardiovascular risk factors in all RA patients, not just those starting glucocorticoids, is crucial, as pretreatment screening reveals the need for preventive interventions and provides baseline values for monitoring 2